These Chip Stocks Jumped On Upbeat Earnings Reports
Amid a mixed week for chip company earnings, two semiconductor stocks got a boost from beat-and-raise reports. SiTime and Synaptics cheered investors with their results and guidance.
Investor's Business Daily · 1天前
Pfizer Will Help Gilead Sciences Make Its Covid-19 Treatment, Remdesivir
The drug giant is one of the firms that will manufacture remdesivir, Gilead Sciences’ experimental antiviral that got emergency approval in May as a treatment for Covid-19.
Barrons.com · 1天前
NIH to test remdesivir with Merck KGaA's interferon therapy as a COVID-19 treatment
The National Institutes of Health said it will conduct a randomized, controlled clinical trial testing a combination of Gilead Sciences Inc.'s remdesivir with Merck KGaA's interferon beta-1a as a treatment for COVID-19 patients. The study plans to enroll 1,0
MarketWatch · 1天前
Pfizer to help manufacture Gilead's remdesivir
Shares of Pfizer Inc. gained 1.0% in premarket trading on Friday after it announced that it will help manufacture Gilead Sciences Inc.'s COVID-19 treatment remdesivir as part of a multi-year agreement. Gilead's stock was up 0.6% on Friday before the market o
MarketWatch · 1天前
UK's Hikma starts manufacturing COVID-19 treatment remdesivir for Gilead
Reuters · 1天前
Diodes (DIOD) Q2 Earnings and Revenues Top Estimates
Diodes (DIOD) delivered earnings and revenue surprises of 8.00% and 2.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 2天前
Diodes Incorporated Reports Second Quarter 2020 Financial Results
Business Wire · 2天前
Earnings Outlook for Diodes
Diodes (NASDAQ: DIOD) announces its next round of earnings this Thursday, August 06. Here is Benzinga's look at Diodes's Q2 earnings report.Earnings and Revenue Sell-side analysts expect Diodes's EPS to be near $0.5 on sales of $283.32 million. Diodes EPS in t